BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/4/2020 9:56:59 AM | Browse: 744 | Download: 2037
 |
Received |
|
2020-05-28 14:43 |
|
Peer-Review Started |
|
2020-05-28 14:43 |
|
First Decision by Editorial Office Director |
|
2020-09-13 14:44 |
|
Return for Revision |
|
2020-09-13 14:44 |
|
Revised |
|
2020-09-26 15:55 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-10-16 11:35 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-10-20 04:00 |
|
Articles in Press |
|
2020-10-20 04:00 |
|
Edit the Manuscript by Language Editor |
|
2020-11-02 00:44 |
|
Typeset the Manuscript |
|
2020-11-30 01:47 |
|
Publish the Manuscript Online |
|
2020-12-04 09:56 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Case Report |
| Article Title |
Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei-Hong Yu, Xie-Jia Li and Fang Yuan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Natural Science Foundation of China |
81770730 |
| the Hunan Provincial Natural Science Fund |
2017JJ2352 |
|
| Corresponding Author |
Fang Yuan, MD, PhD, Chief Doctor, Department of Nephrology, the Second Xiangya Hospital of Central South University, No. 139 Renmin Road, Changsha 410011, Hunan Province, China. yuanfang@csu.edu.cn |
| Key Words |
Renal anemia; Erythropoietin hyporesponsiveness; Hepcidin; Interleukin 6; Roxadustat; Case report |
| Core Tip |
We present a case of refractory erythropoiesis-stimulating agents hyporesponsiveness-related anemia in which oral roxadustat increased and maintained hemoglobin. Roxadustat may be a useful optional treatment for anemia in chronic kidney disease. Future clinical trials are needed to assess potential problems with hypoxia-inducible factor prolyl hydroxylase inhibitors. |
| Publish Date |
2020-12-04 09:56 |
| Citation |
Yu WH, Li XJ, Yuan F. Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report. World J Clin Cases 2020; 8(23): 6048-6055 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i23/6048.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i23.6048 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
